Precision BioSciences (DTIL) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free DTIL Stock Alerts $13.62 +0.64 (+4.93%) (As of 12:47 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePrecision BioSciences (NASDAQ:DTIL) PT Raised to $60.00marketbeat.com - March 28 at 11:28 AMBuy Rating Affirmed for Precision BioSciences as Milestones in Gene Editing Technology Loommarkets.businessinsider.com - March 27 at 10:51 PMDTIL Stock Earnings: Precision BioSciences Misses EPS, Misses Revenue for Q4 2023investorplace.com - March 27 at 12:05 PMPrecision BioSciences Inc Q4 Loss decreases, but misses estimatesmarkets.businessinsider.com - March 27 at 7:47 AMPrecision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updatebusinesswire.com - March 27 at 6:45 AMEarnings Preview: Precision BioSciencesbenzinga.com - March 26 at 10:44 PMPrecision BioSciences Q4 Earnings Previewmsn.com - March 26 at 10:44 PMPrecision BioSciences (DTIL) Set to Announce Earnings on Wednesdayamericanbankingnews.com - March 25 at 2:00 AMPrecision BioSciences (DTIL) Set to Announce Quarterly Earnings on Wednesdaymarketbeat.com - March 21 at 11:26 AMPrecision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024businesswire.com - March 20 at 4:30 PMPrecision BioSciences Flat on New Product Developmentbaystreet.ca - March 19 at 10:10 AMPrecision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathybusinesswire.com - March 19 at 7:00 AMDNAnexus to Showcase the Power of High-Value Multi-Omics Data at the Precision Medicine in IBD Summitfinance.yahoo.com - March 18 at 7:06 PMFender teams up with Fornite to bring its Stratocaster and Precision Bass to the digital realmyahoo.com - March 15 at 10:16 PMMachining company Thomas Precision sells vacant Union County facilitybizjournals.com - March 14 at 11:13 AMThe Anova Precision Cooker Nano sous vide machine drops to a record low of $60msn.com - March 12 at 12:25 AMPrecision BioSciences, Inc. (PBS0.F)finance.yahoo.com - March 7 at 2:52 PMPrecision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC Deficiencybusinesswire.com - March 6 at 8:45 AMDurham gene editing firm raising $40M for Hepatitis B treatmentbizjournals.com - March 4 at 7:01 PMPrecision BioSciences announces public stock offeringinvesting.com - March 2 at 1:54 AMPrecision BioSciences Shares Slide Premarket After Stock Offeringmarketwatch.com - March 1 at 10:52 AMCardiff Oncology, DermTech, Precision Biosciences among healthcare moversmsn.com - March 1 at 10:52 AMPrecision BioSciences Slips Over 16% In Pre-market; Prices Offering Of $40 Mln Of Sharesmarkets.businessinsider.com - March 1 at 10:52 AMPrecision BioSciences Sinks 30%; Sets $40 Mln Stock Offeringmarkets.businessinsider.com - March 1 at 10:52 AMPrecision BioSciences Announces $40.0 Million Offering of Common Stock and Warrantsbusinesswire.com - March 1 at 6:30 AMPrecision BioSciences Announces Proposed Public Offering of Common Stock and Warrantsbusinesswire.com - February 29 at 4:01 PMPrecision BioSciences (DTIL) Price Target Increased by 2900.00% to 80.33msn.com - February 24 at 12:06 AMPrecision BioSciences Enters Patent License Agreement With Caribou Biosciencesmarkets.businessinsider.com - February 20 at 9:21 AMPrecision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou Biosciencesfinance.yahoo.com - February 20 at 9:21 AMPrecision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou Biosciencesbusinesswire.com - February 20 at 7:00 AMBuy Rating Affirmed for Precision BioSciences Amid Progress in HBV Gene Therapy Programmarkets.businessinsider.com - February 15 at 5:55 AMPrecision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical Readinessfinance.yahoo.com - February 14 at 7:34 AMPrecision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical Readinessbusinesswire.com - February 14 at 7:00 AMmarketbeat.com - February 14 at 6:08 AMPrecision BioSciences Promotes Naresh Tanna to Vice President of Investor Relationsfinance.yahoo.com - February 13 at 11:33 AMPrecision BioSciences initiates reverse stock split to maintain Nasdaq listingbizjournals.com - February 13 at 12:09 AMPrecision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseasesfinance.yahoo.com - February 12 at 8:18 AMPrecision BioScience Announces 1-For-30 Reverse Stock Splitmarkets.businessinsider.com - February 9 at 9:27 AMPrecision Optical Technologies Announces General Availability of its Highly Anticipated Passive Optical Network Access Solution -- OpenPath™tmcnet.com - February 6 at 3:02 PMRapid Growth Anticipated in Asia Pacific Precision Fermentation Ingredients Marketfinance.yahoo.com - February 5 at 6:56 PMBucs QB Baker Mayfield wins Pro Bowl Precision Passing eventsports.yahoo.com - February 2 at 10:17 AMPrecision BioSciences Stockholders Approve Reverse Splitmsn.com - January 20 at 7:44 AMNorth Carolina biotechs ink potential $300M deal for cell therapy programbizjournals.com - January 10 at 2:37 PMWhy Precision BioSciences Stock Is Up Todaymsn.com - January 9 at 2:04 PMPrecision BioSciences In Deal With TG Therapeutics On Cell Therapy Azer-celmarkets.businessinsider.com - January 9 at 8:50 AMPrecision BioSciences stock rises on $17.5M license deal with TG Therapeuticmsn.com - January 9 at 8:50 AMPrecision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseasesfinance.yahoo.com - January 9 at 8:50 AMTG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of Precision’s Allogeneic CD19 CAR T Cell Therapy Program for the Treatment of Autoimmune Diseasesfinance.yahoo.com - January 9 at 8:50 AMPrecision BioSciences Announces Approval of First Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECUREfinance.yahoo.com - December 13 at 9:05 AMPrecision BioSciences Announces Publication in Nature Metabolism Supporting ARCUS® In Vivo Gene Editing as a Potentially Curative Treatment for Mitochondrial Diseasesfinance.yahoo.com - December 4 at 9:56 AM Get Precision BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Altcoin FRENZY Alert… (Ad)Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… Click here now to register for the event (FOR FREE!) DTIL Media Mentions By Week DTIL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DTIL News Sentiment▼-0.230.60▲Average Medical News Sentiment DTIL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DTIL Articles This Week▼103▲DTIL Articles Average Week Get Precision BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Achilles Therapeutics News NKGen Biotech News Dyadic International News Protara Therapeutics News Quince Therapeutics News Candel Therapeutics News OKYO Pharma News Gamida Cell News AVROBIO News Entera Bio News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DTIL) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precision BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.